Skip to main content
logo
Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2963
-0.0096 (-3.14%)
At close: Aug 7, 2026, 4:00 PM EDT
0.3049
+0.0086 (2.90%)
After-hours: Aug 7, 2026, 7:38 PM EDT

Mereo BioPharma Group Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.50.5-10-49.3
Revenue Growth
------
Gross Profit
0.370.37-7.431.1325.09
Operating Income
-37.67-40.11-47.36-28.42-52.71-28.31
Net Income
-35.71-41.88-43.25-29.47-40.2117.2
Earnings Per Share
-0.25-0.25-0.30-0.32-0.36-0.34
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
36.2240.9969.857.4168.15127.49
Total Debt
00.26.436.5415.4522.66
Net Cash (Debt)
36.2240.7963.3750.8752.7104.83
Net Cash Growth
-41.33%-35.63%24.57%-3.47%-49.73%1285.75%
Net Cash Per Share
0.230.260.430.390.440.94

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-26.95-30.97-32.83-22.44-46.96-7.08
Capital Expenditures
0-0.02---0.01-0.72
Free Cash Flow
-26.95-30.99-32.83-22.44-46.98-7.81
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
73.60%73.40%-74.26%-50.89%
Operating Margin
-7534.00%-8021.40%--284.16%--57.42%
Pretax Margin
-7142.00%-8375.60%--299.98%-39.05%
Profit Margin
-7142.00%-8375.60%--294.66%-34.90%
FCF Margin
-5390.80%-6198.20%--224.43%--15.83%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
94.59132.62-32.35-3.80